This section of Viatris.com contains information that may not be suitable for use in all countries due to varied regulatory requirements, data protection requirements and practices or medical practices, and distinctions among product approval and commercial availability. The information contained in each news release or statement posted on this page is presented as of the date it was issued. The company undertakes no obligation to update the information for changes or subsequent events after the date it was originally issued.
- Jun 30, 202099.6% of Shares Voted in Favor of the Transaction
- Mar 26, 2020Due to global impact of COVID-19 pandemic, transaction now expected to close in the second half of 2020 and Mylan's EGM moved to June 30
- Feb 27, 2020Pfizer's Upjohn Division CFO Sanjeev Narula selected for leadership role at combined company